FDA
approval
· 2014-01-08
FDA Approved: PHENYTEK — Supplemental Application (Mylan Pharmaceuticals Inc.)
Summary
The FDA approved a supplemental application for PHENYTEK, allowing an extended phenytoin sodium formulation to be marketed under the ANDA, broadening formulatio…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for PHENYTEK (EXTENDED PHENYTOIN SODIUM)